Emily Penman

437 citations
8 papers · 366 indexed · h-index 5
Topics
Breast Cancer Treatment Studies (2 papers)Global Cancer Incidence and Screening (2 papers)Cancer and Skin Lesions (2 papers)
Partner nations
United States

In The Last Decade

Emily Penman

8 papers receiving 359 citations

Peers

Emily Penman
Comparison fields: 5 of 57
  • Immunology 263
  • Oncology 141
  • Molecular Biology 98
  • Cancer Research 54
  • Pulmonary and Respiratory Medicine 40
Replace Weijiao Du with:
Weijiao Du China
М. I. Shkolnik Russia
Jemima Escamilla United States
Yosuke Kubo Japan
Jessica Kline United States
Linda M. Hartkamp Netherlands
Matthäus Felsenstein Germany
Kathrin Meinhardt Germany
Yusuke Shinchi Japan
Emily Penman relative to Weijiao Du China Weijiao Du's profile →
Citations per field
00.5×1.5×
Weijiao Du · 1×
Citations per year

Countries citing papers authored by Emily Penman

Since Specialization
Citations

This map shows the geographic impact of Emily Penman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Penman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Penman more than expected).

Fields of papers citing papers by Emily Penman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Penman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Penman. The network helps show where Emily Penman may publish in the future.

Co-authorship network of co-authors of Emily Penman

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Penman. A scholar is included among the top collaborators of Emily Penman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Penman. Emily Penman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 313
2 4
3
Radiation Associated Angiosarcoma: Case Series from a Community Cancer Center and Review of the Literature.
1
4 8
5 10
6 1
7
The MRI appearance of Paget's disease of the nipple: images from a single case.
3
8 26

About Emily Penman

Emily Penman is a scholar working on Dermatology, Oncology and Cancer Research, having authored 8 papers that have together received 366 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (2 papers), Global Cancer Incidence and Screening (2 papers) and Cancer and Skin Lesions (2 papers). The work is most often cited by research in Immunology (263 citations), Oncology (141 citations) and Cancer Research (54 citations). Emily Penman has collaborated with scholars based in United States. Frequent co-authors include Dario C. Altieri, Vinit Kumar, Hong Du, Dmitry I. Gabrilovich, Pingyan Cheng, Sridevi Mony, Judith C. McCaffrey, Cong Yan, Xiaowei Xu and Michael J. Guarino. Their work appears in journals such as Immunity, The Journal of Immunology and Annals of Vascular Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026